BioForce Q3 2026: Zero Revenue, $31,696 Cash, Going Concern and Material Weakness Reiterated
BFNH filed a Earnings and Guidance on light trading volume (0.3× avg).
Summary
BioForce reported zero revenue, $31,696 of cash and a $341,680 third-quarter net loss, while repeating going-concern doubt and disclosing that internal controls were not effective. The oil and gas pivot has added leases and prepaid assets but no production.
Key Events · Earnings and Guidance · BFNH
-
Zero Revenue, Wider Q3 Loss
Sales were $0 for the three and nine months ended September 30, 2026. Q3 net loss was $341,680 versus $115,915 a year earlier, driven by general and administrative expense of $307,930 versus $10,165.
-
Cash Drops to $31,696
Cash was $31,696 at September 30, 2026 against $277,033 of current liabilities. Nine-month operating cash burn was $114,682, funded mainly by $143,592 of related-party proceeds.
-
Going Concern Doubt Reiterated
Management states recurring losses and an accumulated deficit of $162,617,526 raise substantial doubt about the ability to continue as a going concern, and that once settlement funds are used up it will rely on officer loans.
-
Material Weakness Disclosed
Management concluded disclosure controls and internal control over financial reporting were not effective at September 30, 2026 due to inadequate segregation of duties and a lack of review over financial reporting.
Analysis · BFNH · Industrial Applications And Services
BioForce still generates no revenue, and it burned $114,682 of cash in the first nine months of 2026, leaving just $31,696 in the bank against $277,033 of current liabilities. The reported nine-month net loss of $205,410 looks small only because Chairman Merle Ferguson forgave $502,373 of amounts owed to him in April 2026; without that non-cash benefit, the loss would have been roughly $707,783. Management repeats that substantial doubt exists about the company's ability to continue as a going concern and says that once settlement funds run out it will depend on officer loans to pay expenses. The company also disclosed that its disclosure controls and internal control over financial reporting were not effective at September 30, 2026 because of inadequate segregation of duties. The pivot into oil and gas has added $234,525 of capitalized leases and $1,972,440 of prepaid expenses, but no wells have been drilled and no reserves are booked, so the balance sheet value rests on undeveloped acreage rather than production.
How filings like this one have moved
In the 30 days to Nov 9, 2026, 47.1% of the 1533 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BFNH was trading at $6.69 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $224.4M. The 52-week trading range was $0.18 to $10.99. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.